StonvexLoading…
StonvexStonvexStonvexCore line items from NVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $54.53B | $50.32B | $45.44B | $42.21B |
Operating Income | $17.64B | $14.54B | $9.77B | $7.95B |
Net Income | $13.97B | $11.94B | $14.85B | $6.96B |
EPS (Diluted) | $7.15 | $5.87 | $7.10 | $3.17 |
Total Assets | $110.95B | $102.25B | $99.94B | $117.45B |
Total Liabilities | $64.40B | $58.12B | $53.20B | $58.03B |
Cash & Equivalents | $11.44B | $11.46B | $13.39B | $7.52B |
Free Cash Flow OCF − CapEx | $17.60B | $16.25B | $13.40B | $13.32B |
Shares Outstanding | 1.91B | 1.98B | 2.04B | 2.12B |